Medical Treatments for Prostate CancerThere are many different medical treatments for prostate cancer that involve the clinical care of a healthcare professional. These treatments include expectant therapy, surgery, radiation therapy, hormone therapy, and chemotherapy. Expectant therapy is to carefully observe and monitor the prostate cancer. Because prostate cancer cells often spread very slowly, many older men who have the disease may not need more extensive treatment. However, expectant therapy usually includes routine physician examinations, including digital rectal exams and PSA tests. The different types of surgery for prostate cancer are radical prostatectomy - an open-surgery procedure in which the entire prostate gland and surrounding tissue are removed. Transurethral resection of the prostate (TURP) - surgery to remove part of the prostate gland that surrounds the urethra. Cryosurgery - this procedure involves killing the cancer cells by freezing them with a small metal tool placed in the tumor. Side effects of prostate cancer surgery include incontinence and impotence. Incontinence is the inability to control urine and may result in dribbling of urine, especially immediately after surgery. Normal control usually returns within weeks or months after surgery. Impotence is the inability to achieve an erection. For a month, or so, after surgery, most men are not able to get an erection. Eventually, approximately 40 to 60 percent of men will be able to get an erection sufficient for sexual intercourse, but without ejaculation of semen, since removal of the prostate gland prevents that process.Radiation therapy uses high energy rays to kill or shrink cancer cells, and to decrease their ability to divide. Radiation is often used to treat prostate cancer that is still confined to the prostate gland, or has spread only to nearby tissue. If the disease is advanced, radiation may be used to reduce the size of the tumor and to provide relief from symptoms. Possible side effects of radiation for prostate cancer may include diarrhea, with or without blood in the stool, and colitis, problems associated with urination, a degree of impotence (inability to get an erection), which may occur within two years of radiation therapy. The goal of hormone therapy is to lower the level of male hormones in the body, particularly testosterone. Hormone therapy does not cure the cancer, and is often used to treat persons whose cancer has spread or recurred after treatment. Produced mainly in the testicles, testosterone causes prostate cancer cells to grow. Thus, reduced testosterone levels can make the prostate cancer shrink and become less active. Most studies show that hormone therapy works better if it is started early. Chemotherapy is the use of powerful, anti-cancer medications to kill cancer cells.. Hospitalization may be needed to monitor treatment and chemotherapy's side effects. Common side effects of chemotherapy include: nausea and vomiting, hair loss, anemia, reduced ability of blood to clot, mouth sores, increased likelihood of developing infections, fatigue. Most side effects disappear once treatment is stopped. |
| catalona prostate |
|
Who owns your body; Man wants prostate he donated to follow doctor After Catalona removed Ward's cancerous prostate, Ward donated the gland for Catalona's research at Washington University in St. Louis. Prostate Cancer - Interview with Dr. William J. Catalona Interview with Dr. William J. Catalona for the Special Topic Prostate Cancer. Dr. Catalona - Prostate Cancer, PSA Study, and Nerve Sparing Dr. Catalona's Urological Research Foundation provides prostate cancer information, including psa study, prostatectomy, genetic research. Amazon.com: Prostate Cancer: Books: William Catalona Amazon.com: Prostate Cancer: Books: William Catalona by William Catalona. Screening for prostate cancer -- Harwood and Catalona 315 (7101 Editorâ“The debate about the desirability of screening for prostate cancer as outlined in the editorial by Steven H Woolf has centred on the ability to Screening for prostate cancer -- Harwood and Catalona 315 (7101 Medline; Smith DS, Schneider MK, Catalona WJ. Short-term outcomes with screen-detected prostate cancer abstract. J Urol 1997;157(suppl):426. Viewpoint: Expanding Prostate Cancer Screening -- Catalona et al Loeb S, Roehl KA, Antenor JA, Catalona W, Suarez BK, Nadler RB. Baseline Prostate Specific Antigen (PSA) Compared with Median PSA for Age Group as Predictor Viewpoint: Expanding Prostate Cancer Screening -- Catalona et al Viewpoint: Expanding Prostate Cancer Screening. right arrow William J. Catalona, MD; Stacy Loeb, MD; and Misop Han, MD. 21 March 2006 | Volume 144 Issue 6 Prostate Cancer Dr. Catalona, an upper echelon surgeon from St. Louis, subscribes to prostate removal surgery as the ultimate weapon in securing old age for PCa patients. William J. Catalona, MD Roehl KA, Antenor JAV, Catalona WJ. Serial biopsy results in prostate cancer Han M, Gann PH, Catalona WJ. Prostate-specific antigen and screening for Dr. Catalona's Prostate Cancer Information Site Dr. Catalona's journal articles from various publications · Dr. Catalona's genetic research for prostate cancer · Donate to the URF for prostate cancer |
| catalona prostate |
|
escort massage prostate electro prostate stimulation advance cancer prostate treatment beating cancer prostate surgery without |